Julie Lucifora

10PUBLICATIONS
50CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsInnate immunityGene and molecular therapyCheminformatics and quantitative structure-activity relationshipsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 02, 2025
Targeting HBV with RNA interference: Paths to cure.

Matteo Iannacone, Cristian G Beccaria, Lena Allweiss

|May 12, 2025
TRIM proteins: A 'swiss army knife' of antiviral immunity.

Elise Chabot, David Durantel, Julie Lucifora

|Apr 14, 2023
Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity.

Anne-Flore Legrand, Julie Lucifora, Benoît Lacombe

|Jan 27, 2023
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure.

Lena Allweiss, Barbara Testoni, Mei Yu

|Aug 17, 2022
Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy.

Nadja Meumann, Marti Cabanes-Creus, Moritz Ertelt

|Mar 07, 2022
Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translation.

Romain Barnault, Claire Verzeroli, Carole Fournier

Pageof 2

Frequent Collaborators

4 joint publications

David Durantel

2 joint publications

Anna Salvetti

2 joint publications

Suzanne Faure-Dupuy

2 joint publications

Maura Dandri